Abstract
Unlike small molecule drugs, therapeutic protein pharmaceuticals must not only have the correct amino acid sequence and modifications, but also the correct conformation to ensure safety and efficacy. Here, we describe a method for comparison of therapeutic protein conformations by hydroxyl radical protein footprinting using liquid chromatography-mass spectrometry (LC-MS) as an analytical platform. Hydroxyl radical protein footprinting allows for rapid analysis of the conformation of therapeutic proteins based on the apparent rate of oxidation of various amino acids by hydroxyl radicals generated in situ. Conformations of Neupogen®, a patented granulocyte colony-stimulating factor (GCSF), were compared to several expired samples of recombinant GCSF, as well as heat-treated Neupogen®. Conformations of different samples of the therapeutic proteins interferon α-2A and erythropoietin were also compared. Differences in the hydroxyl radical footprint were measured between Neupogen® and the expired or mishandled GCSF samples, and confirmed by circular dichroism spectroscopy. Samples that had identical circular dichroism spectra were also found to be indistinguishable by hydroxyl radical footprinting. The method is applicable to a wide variety of therapeutic proteins and formulations through the use of separations techniques to clean up the protein samples after radical oxidation. The reaction products are stable, allowing for flexibility in sample handling, as well as archiving and reanalysis of samples. Initial screening can be performed on small amounts of therapeutic protein with minimal training in LC-MS, but samples with structural differences from the reference can be more carefully analyzed by LC-MS/MS to attain higher spatial resolution, which can aid in engineering and troubleshooting.
Similar content being viewed by others
References
Locatelli F, Del Vecchio L, Pozzoni P. Pure Red-cell aplasia “epidemic”—mystery completely revealed? Perit Dial Int. 2007;27(Supplement 2):S303–7.
McKoy JM, Stonecash RE, Cournoyer D, Rossert J, Nissenson AR, Raisch DW, et al. Epoetin‐associated pure red cell aplasia: past, present, and future considerations. Transfusion. 2008;48(8):1754–62.
Kessler M, Goldsmith D, Schellekens H. Immunogenicity of biopharmaceuticals. Nephrol Dial Transplant. 2006;21 suppl 5:v9.
Srebalus Barnes CA, Lim A. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrom Rev. 2007;26(3):370–88.
Bobst CE, Abzalimov RR, Houde D, Kloczewiak M, Mhatre R, Berkowitz SA, et al. Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches. Anal Chem. 2008;80(19):7473–81.
Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products: Mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv. 2012;30(1):210–22.
Konermann L, Pan J, Liu YH. Hydrogen exchange mass spectrometry for studying protein structure and dynamics. Chem Soc Rev. 2011;40:1224–34.
Kaltashov IA, Bobst CE, Abzalimov RR, Wang G, Baykal B, Wang S. Advances and challenges in analytical characterization of biotechnology products: Mass spectrometry-based approaches to study properties and behavior of protein therapeutics. Biotechnol Adv. 2012;30(1):210–22.
Mendoza VL, Vachet RW. Probing protein structure by amino acid‐specific covalent labeling and mass spectrometry. Mass Spectrom Rev. 2009;28(5):785–815.
Konermann L, Stocks BB, Pan Y, Tong X. Mass spectrometry combined with oxidative labeling for exploring protein structure and folding. Mass Spectrom Rev. 2010;29(4):651–67.
Xu G, Chance MR. Radiolytic modification and reactivity of amino acid residues serving as structural probes for protein footprinting. Anal Chem. 2005;77(14):4549–55.
Buxton GV, Greenstock CL, Helman WP, Ross AB. Critical review of rate constants for reactions of hydrated electrons, hydrogen atoms and hydroxyl radicals (.Oh/.O−) in aqueous solution. J Phys Chem Ref Data. 1988;17(2):513–886.
Charvátová O, Foley B, Bern M, Sharp J, Orlando R, Woods R. Quantifying protein interface footprinting by hydroxyl radical oxidation and molecular dynamics simulation: application to galectin-1. J Am Soc Mass Spectrom. 2008;19(11):1692–705.
Gau BC, Sharp JS, Rempel DL, Gross ML. Fast photochemical oxidation of protein footprints faster than protein unfolding. Anal Chem. 2009;81(16):6563–71.
Watson C, Janik I, Zhuang T, Charva Tova O, Woods R, Sharp J. Pulsed electron beam water radiolysis for submicrosecond hydroxyl radical protein footprinting. Anal Chem. 2009;81(7):2496–505.
Hambly DM, Gross ML. Laser flash photolysis of hydrogen peroxide to oxidize protein solvent-accessible residues on the microsecond timescale. J Am Soc Mass Spectrom. 2005;16(12):2057–63.
Desjardins P, Hansen JB, Allen M (2009) Microvolume protein concentration determination using the NanoDrop 2000c spectrophotometer. J Visualized Experiments: JoVE (33): 1610
Woody RW. Circular dichroism. Biochem Spectrosc. 1995;246:34–71.
Zink T, Ross A, Lueers K, Cieslar C, Rudolph R, Holak TA. Structure and dynamics of the human granulocyte colony-stimulating factor determined by NMR spectroscopy. Loop mobility in a four-helix-bundle protein. Biochemistry. 1994;33(28):8453–63.
Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med. 2004;10(Suppl):S10–7.
Klaus W, Gsell B, Labhardt AM, Wipf B, Senn H. The three-dimensional high resolution structure of human interferon alpha-2a determined by heteronuclear NMR spectroscopy in solution. J Mol Biol. 1997;274(4):661–75.
Cheetham JC, Smith DM, Aoki KH, Stevenson JL, Hoeffel TJ, Syed RS, et al. NMR structure of human erythropoietin and a comparison with its receptor bound conformation. Nat Struct Biol. 1998;5(10):861–6.
Wang X, Watson C, Sharp JS, Handel TM, Prestegard JH. Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data. Structure. 2011;19(8):1138–48.
ACKNOWLEDGMENTS
This project was supported by grants from the National Center for Research Resources (5P41RR005351-23) and the National Institute of General Medical Sciences (8 P41 GM103390-23) from the National Institutes of Health. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. We would also like to thank Dr. Jeffrey Urbauer of The University of Georgia for use of his CD instrumentation. JSS would also like to thank Dr. Marshall Bern for numerous productive conversations on the topics explored here.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editor: Michael Bartlett
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table S1
Independent two-tailed Student’s t test of HRF between GCSF samples (DOC 34 kb)
Table S2
Independent two-tailed Student’s t test of HRF between IFN samples and IFN 2005 (DOC 28 kb)
Table S3
Independent two-tailed Student’s t test of HRF between EPO samples and EPO June 2009 (DOC 26 kb)
Rights and permissions
About this article
Cite this article
Watson, C., Sharp, J.S. Conformational Analysis of Therapeutic Proteins by Hydroxyl Radical Protein Footprinting. AAPS J 14, 206–217 (2012). https://doi.org/10.1208/s12248-012-9336-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-012-9336-7